Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results.
López Fernández MJ, Narejos S, Castro A, Echave-Sustaeta JM, Forner MJ, Arana-Arri E, Molto J, Bernad L, Pérez-Caballero R, Prado JG, Raïch-Regué D, Boreika R, Izquierdo-Useros N, Trinité B, Blanco J, Puig-Barberà J, Natalini Martínez S.
López Fernández MJ, et al. Among authors: forner mj.
Vaccines (Basel). 2024 Jul 25;12(8):840. doi: 10.3390/vaccines12080840.
Vaccines (Basel). 2024.
PMID: 39203967
Free PMC article.